Status:
RECRUITING
Comparison of Non-Invasive Blood Pressure (NIBP) Using the Biobeat Device with an Invasive Arterial Line Catheter
Lead Sponsor:
Biobeat Technologies Ltd.
Collaborating Sponsors:
The Chaim Sheba Medical Center
Conditions:
Blood Pressure
Heart Diseases
Eligibility:
All Genders
18+ years
Brief Summary
In this clinical study the investigators will compare blood pressure measurements obtained using the non-invasive, wireless Biobeat monitoring device (both a wrist watch and a patch configuration) to ...
Detailed Description
The Biobeat non-invasive, wireless monitoring device is based on reflective photoplethysmograph (PPG) technology. It measures several vital signs, including blood pressure, stroke volume, pulse rate, ...
Eligibility Criteria
Inclusion
- 18 years old and above patients of both sexes arriving immediately after cardiac surgery to the intensive care unit with a radial/femoral arterial line and or a Swan Ganz catheter and in need for blood pressure monitoring.
Exclusion
- Refusal to participate
- Patients with no need or no technical capability to have an arterial line
- Pregnant women
- Individuals under the age of 18 years
- Patients with lack of judgment/mental illness
- Patients working in the Sheba Medical Center
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04071015
Start Date
June 15 2020
End Date
December 1 2026
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Sheba Medical Center, Tel Hashomer
Ramat Gan, Israel, 526560